Patents by Inventor George R. Painter, III

George R. Painter, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination Therapy to Treat Hepatitis B Virus
    Publication number: 20090247487
    Abstract: The present invention is directed to a method for treating hepatitis B virus infection in humans comprising administering a synergistically effective amount of agents having known anti-hepatitis B virus activity in combination or alternation. Specifically, the invention is directed to a method for treating hepatitis B virus infection comprising administering FTC in combination or alternation with penciclovir, famciclovir or Bis-POM-PMEA. Additionally, the invention is directed to a method for treating hepatitis B virus infection comprising administering L-FMAU in combination or alternation with DAPD, penciclovir or Bis-POM-PMEA. The invention is further directed to a method for treating hepatitis B virus infection comprising administering DAPD in combination or alternation with Bis-POM-PMEA.
    Type: Application
    Filed: June 12, 2009
    Publication date: October 1, 2009
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Phillip A. Furman, George R. Painter, III, David W. Barry, Franck Rousseau
  • Combination therapy to treat hepatitis B virus
    Patent number: 7572800
    Abstract: The present invention is directed to a method for treating hepatitis B virus infection in humans comprising administering a synergistically effective amount of agents having known anti-hepatitis B virus activity in combination or alternation. Specifically, the invention is directed to a method for treating hepatitis B virus infection comprising administering FTC in combination or alternation with penciclovir, famciclovir or Bis-POM-PMEA. Additionally, the invention is directed to a method for treating hepatitis B virus infection comprising administering L-FMAU in combination or alternation with DAPD, penciclovir or Bis-POM-PMEA. The invention is further directed to a method for treating hepatitis B virus infection comprising administering DAPD in combination or alternation with Bis-POM-PMEA.
    Type: Grant
    Filed: February 25, 2003
    Date of Patent: August 11, 2009
    Assignee: Gilead Sciences, Inc.
    Inventors: Phillip A. Furman, George R. Painter, III, David W. Barry, Franck Rousseau
  • Combination therapy to treat hepatitis B virus
    Patent number: 6528515
    Abstract: The present invention is directed to a method for treating hepatitis B virus infection in humans comprising administering a synergistically effective amount of agents having known anti-hepatitis B virus activity in combination or alternation. Specifically, the invention is directed to a method for treating hepatitis B virus infection comprising administering FTC in combination or alternation with penciclovir, famciclovir or Bis-POM-PMEA. Additionally, the invention is directed to a method for treating hepatitis B virus infection comprising administering L-FMAU in combination or alternation with DAPD, penciclovir or Bis-POM-PMEA. The invention is further directed to a method for treating hepatitis B virus infection comprising administering DAPD in combination or alternation with Bis-POM-PMEA.
    Type: Grant
    Filed: November 2, 1999
    Date of Patent: March 4, 2003
    Assignee: Triangle Pharmaceuticals, Inc.
    Inventors: Phillip A. Furman, George R. Painter, III, David W. Barry, Franck Rousseau
  • Antiviral nucleoside combination
    Patent number: 5234913
    Abstract: Synergistic combinations of nucleoside derivatives, pharmaceutical formulations containing said combinations and use of the combinations in the treatment of retroviral infections are disclosed.
    Type: Grant
    Filed: March 5, 1992
    Date of Patent: August 10, 1993
    Assignee: Burroughs Wellcome Co.
    Inventors: Phillip A. Furman, Jr., George R. Painter, III